Evidence map›Paper›PMID 39030721›Full record

ArticleAmerican journal of epidemiology2025

The role of prescription opioid and cannabis supply policies on opioid overdose deaths.

Magdalena Cerdá, Katherine Wheeler-Martin, Emilie Bruzelius, Christine M Mauro, Stephen Crystal, Corey S Davis, Samrachana Adhikari, Julian Santaella-Tenorio, Katherine M Keyes, Kara E Rudolph and 2 more

Abstract read
In one paragraph

Article in American journal of epidemiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Magdalena CerdáCenter for Opioid Epidemiology and Policy, Department of Population Health, NYU Grossman School of Medicine, New York, NY, United States.ORCID 0000-0001-8441-7046
Katherine Wheeler-MartinCenter for Opioid Epidemiology and Policy, Department of Population Health, NYU Grossman School of Medicine, New York, NY, United States.ORCID 0000-0002-6806-4233
Emilie BruzeliusDepartment of Epidemiology, Columbia University, New York, NY, United States.ORCID 0000-0001-6384-9747
Christine M MauroDepartment of Biostatistics, Columbia University , New York, NY, United States.ORCID 0000-0001-6065-8128
Stephen CrystalCenter for Health Services Research, Institute for Health, Health Care Policy, and Aging Research, Rutgers University, New Brunswick, NJ, United States.ORCID 0000-0003-0366-7583
Corey S DavisNetwork for Public Health Law, Los Angeles, CA, United States.ORCID 0000-0002-6278-5013
Samrachana AdhikariCenter for Opioid Epidemiology and Policy, Department of Population Health, NYU Grossman School of Medicine, New York, NY, United States.ORCID 0000-0001-9954-5999
Julian Santaella-TenorioCenter for Opioid Epidemiology and Policy, Department of Population Health, NYU Grossman School of Medicine, New York, NY, United States.ORCID 0000-0003-3060-5994
Katherine M KeyesDepartment of Epidemiology, Columbia University, New York, NY, United States.ORCID 0000-0002-5624-021X
Kara E RudolphDepartment of Epidemiology, Columbia University, New York, NY, United States.ORCID 0000-0002-9417-7960
Deborah HasinDepartment of Epidemiology, Columbia University, New York, NY, United States.ORCID 0000-0002-6533-7021
Silvia S MartinsDepartment of Epidemiology, Columbia University, New York, NY, United States.ORCID 0000-0003-3059-9993

Funding

New Jersey Alliance for Clinical Translational Science: NJ ACTSUL1TR003017 · NCATS · RUTGERS BIOMEDICAL/HEALTH SCIENCES-RBHS · PI PANETTIERI, REYNOLD ALEXANDER · 2019 to 2023
$28.9M
Substance Abuse Epidemiology Training Program (SAETP) at Columbia UniversityT32DA031099 · NIDA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI DEBORAH S HASIN, Silvia Saboia Martins · 2012 to 2026
$6.1M
Examining the Synergistic Effects of Cannabis and Prescription Opioid Policies on Chronic Pain, Opioid Prescribing, and Opioid OverdoseR01DA045872 · NIDA · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI CERDA, MAGDALENA, MARTINS, SILVIA SABOIA · 2019 to 2023
$4.3M
Impact of Medical and Recreational Marijuana Laws On Cannabis, Opioids And Psychiatric Medications: National Study of VA Patients, 2000 - 2024R01DA048860 · NIDA · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI HASIN, DEBORAH S · 2019 to 2023
$4.1M
Improving MOUD Access, Opioid-Related Outcomes and Equity Among Medicare Beneficiaries with DisabilityR01DA057568 · NIDA · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · PI Stephen Crystal · 2022 to 2026
$3.7M
Opioid Overdoses among Medicaid Beneficiaries: Predictors, Outcomes, and State Policy EffectsR01DA047347 · NIDA · RUTGERS, THE STATE UNIV OF N.J. · PI CRYSTAL, STEPHEN · 2019 to 2022
$3.1M
AHRQ HHS R18 HS023258NCATS NIH HHS UL1 TR003017NIDA NIH HHS R01 DA045872NIDA NIH HHS R01 DA047347NIDA NIH HHS R01 DA048860NIDA NIH HHS R01 DA057568NIDA NIH HHS T32 DA031099
6 · The paper itself

Abstract

Mandatory prescription drug monitoring programs and cannabis legalization have been hypothesized to reduce overdose deaths. We examined associations between prescription monitoring programs with access mandates (must-query PDMPs), legalization of medical and recreational cannabis supply, and opioid overdose deaths in United States counties in 2013-2020. Using data on overdose deaths from the National Vital Statistics System, we fit Bayesian spatiotemporal models to estimate risk differences and 95% credible intervals (CrIs) in county-level opioid overdose deaths associated with enactment of these state policies. Must-query PDMPs were independently associated with on average 0.8 (95% CrI, 0.5-1.0) additional opioid-involved overdose deaths per 100 000 person-years. Legal cannabis supply was not independently associated with opioid overdose deaths in this time period. Must-query PDMPs enacted in the presence of legal (medical or recreational) cannabis supply were associated with 0.7 (95% CrI, 0.4-0.9) more opioid-involved deaths relative to must-query PDMPs without any legal cannabis supply. In a time when overdoses are driven mostly by nonprescribed opioids, stricter opioid prescribing policies and more expansive cannabis legalization were not associated with reduced overdose death rates. This article is part of a Special Collection on Mental Health.

Indexed as

Analgesics, OpioidCannabisDrug OverdoseMedical MarijuanaOpiate OverdosePrescription Drug Monitoring ProgramsBayes TheoremHumansUnited StatesAnalgesics, OpioidMedical MarijuanacannabismarijuanaopioidoverdosePDMPpolicyspatiotemporal

Identifiers

PMID39030721
PMCPMC12168759

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.